US Pharma MarketingThe post SQ Innovation’s home care oedema treatment shows benefit in new data readout appeared first on Medical Device Network.
SQ Innovation’s home care oedema treatment shows benefit in new data readout
SQ Innovation’s topline data evaluating its Lasix Onyu home care oedema treatment versus SoC IV was shared at the 2026 Heart Failure Congress in Barcelona. SQ Innovation’s topline data evaluating its Lasix Onyu home care oedema treatment versus SoC IV was shared at the 2026 Heart Failure Congress in Barcelona. Common in heart failure patients, oedema often occur in the ankles, legs, and feet. Credit: jittawit21 / Shutterstock.com SQ Innovation’s Lasix Onyu, a drug-device combination therapy for fluid retention (oedema) treatment in chronic heart failure patients, has demonstrated value in comparison to hospital-based care for the condition. A common condition…
SQ Innovation’s topline data evaluating its Lasix Onyu home care oedema treatment versus SoC IV was shared at the 2026 Heart Failure Congress in Barcelona.
Source: Medical Device Network